RecruitingNot ApplicableNCT06799715

Assessments of Metabolic Responses to Acute Oral Administration of Sucrose, Glucose, and Fructose

Assessments of Metabolic Responses to Acute Oral Administration of Sucrose, Glucose, and Fructose in Healthy Humans


Sponsor

University Hospital, Basel, Switzerland

Enrollment

20 participants

Start Date

Feb 6, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This project aims to compare the acute metabolic effects of the three sweeteners sucrose, glucose, and fructose on GI hormones (GLP-1, PYY, CCK, and ghrelin). Furthermore, glycemic control, erythritol and xylitol concentrations, blood coagulation function , blood lipids, uric acid, high-sensitive C-reactive protein (hsCRP), complete blood count, gastric emptying, appetite-related sensations, and GI symptoms will be investigated.


Eligibility

Min Age: 18 YearsMax Age: 55 Years

Inclusion Criteria4

  • Healthy, non-diabetic (glycated hemoglobin (HbA1c) \< 5.7%, fasting glucose \< 5.6 mmol/L), and normal weight participants with a body-mass index (BMI) of 19.0-24.9 kg/m2, parameters of complete blood count within normal range
  • Age 18-55 years
  • Stable body weight (± 5%) for at least three months
  • Able to give informed consent as documented by signature

Exclusion Criteria9

  • Fructose intolerance
  • Any pre-existing diet (e.g., vegetarian diet, vegan diet, sugar free diet, paleo diet, Atkins diet, ketogenic diet) that deviates from normal eating habits
  • Regular consumption (\>1/ week) of erythritol or xylitol
  • Regular intake of medications, except contraceptives
  • Pre-existing impairment of blood coagulation/thrombocyte function (e.g. hereditary, regular intake of anti-coagulant agents (e.g. NSAIDs, heparin, warfarin, etc.))Chronic or clinically relevant acute infections/diseases
  • Substance abuse (more than 1 glass wine/beer per day; regular consumption of cannabis, consumption of cocaine, heroin, etc.), regular smoking
  • Pregnancy: although no contraindication, pregnancy might influence metabolic state. Women who are pregnant or have the intention to become pregnant during the course of the study are excluded. In female participants a urine pregnancy test is carried out upon screening.
  • Shift worker
  • Participation in another study with investigational drug within the 30 days preceding and during the present study

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTSucrose

33.5g sucrose dissolved in 300mL tap water

DIETARY_SUPPLEMENTGlucose

33.5g glucose dissolved in 300mL tap water

DIETARY_SUPPLEMENTFructose

33.5g fructose dissolved in 300mL tap water

DIETARY_SUPPLEMENTWater

300mL water


Locations(1)

St. Claraspital

Basel, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06799715


Related Trials